Statistics

Total Visits

Views
Safety of cabazitaxel (Cbz) in patients (pt) with metastatic transitional-cell carcinoma (mTCC) progressing to cisplatin-based chemotherapy: Results from the JEVTCC-SOGUG Study50

Select a period of time:

Number of views in the range

Views
Safety of cabazitaxel (Cbz) in patients (pt) with metastatic transitional-cell carcinoma (mTCC) progressing to cisplatin-based chemotherapy: Results from the JEVTCC-SOGUG Study14

Views

Views
November 20250
December 20250
January 20262
February 20260
March 20263
April 20267
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Mexico2
Argentina1
Canada1
Colombia1
Ecuador1
Netherlands1
 

Top cities views

Views
San Jose2
Amsterdam1
Ashburn1
Benito Juarez1
Buffalo1
Casbas1
Gustavo Adolfo Madero1
Montreal1
Newark1
Santa Clara1